Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...
Ryan Dhillon | April 11, 2024 |

Royalties Inc. provides insight into the exciting world of music royalties

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Joining us today is Royalties Inc. (CSE:RI) Chairman and CEO Tim Gallagher, who is here to share all the information about the company and what it has to o...
Coreena Robertson | January 24, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |

Buzz on the Bullboards: Of interest rates and rebates

Inflation continues to surge out of control to the point where grocery rebates seem to offer little help to struggling Canadians. This holiday-shortened week, markets are adjusting to the U.S. Federal Reserve’s move to raise interest rates. Investors a...
Jonathon Brown | July 6, 2023 |

Buzz on the Bullboards: Too big to fail?

It has been a hot week for much of North America and it’s not just the temperature that’s rising, we are seeing a surge in investor discussion on the Bullboards, as well. Now that we’re officially in the second half of 2...
Jonathon Brown | June 29, 2023 |

Buzz on the Bullboards: Can health care and energy stocks help “recession proof” your portfolio?

Investors often keep focused on the most consistent plays, when times of renewed uncertainty rears its head in the markets. The recent wave of uncertainty follows the earlier wave, both caused by the U.S. debt ceiling deal and worries over an impending rec...
Jonathon Brown | June 1, 2023 |

HAVN Life Sciences: a biotech company developing technology-focused, data-driven psychedelic therapi

HAVN Life Sciences is a biotech company focused on psychedelic therapies. The Vancouver-based company develops technology-focused, data-driven, and medical-based solutions. Joining us here at the Top Line today is HAVN Life Sciences CEO, Tim Moore. Welcome back a...
Simon Druker | March 30, 2023 |

Sitka Gold: Exploring gold, silver and copper properties of merit

Our next company is a well-funded mineral exploration company focused on exploring economically viable mineral deposits. Sitka Gold has four projects, but today we will dive into the RC Gold Project in the Yukon and the Alpha Gold Property in Nevada to see what&CloseC...
Brieanna McCutcheon | March 27, 2023 |

Buzz on the Bullboards: The deep freeze

From coast-to-coast winter storms, the constant “sabre-rattling” between the world’s largest militaries, and the U.S. Supreme Court deciding whether it should essentially “upend the internet” as we know it, there...
Jonathon Brown | February 23, 2023 |

Buzz on the Bullboards: Weathering the Storm?

Sponsored by Now that we’re officially in the second half of 2022, analysts are warning that the rest of the year could prove to be challenging for the stock market. While the first half of the year a...
Jocelyn Aspa | July 7, 2022 |
1 2 3 4 5 6 7 8 9 10 ...